These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 3002650)

  • 21. Japanese encephalitis immunization in South Korea: past, present, and future.
    Sohn YM
    Emerg Infect Dis; 2000; 6(1):17-24. PubMed ID: 10653564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
    Luo D; Yin H; Xili L; Song J; Wang Z
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Japanese encephalitis vaccines: moving away from the mouse brain.
    Zanin MP; Webster DE; Martin JL; Wesselingh SL
    Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Japanese encephalitis vaccination, with reference to travellers to Seoul, Korea.
    Can Dis Wkly Rep; 1988 Sep; 14(36):161-2. PubMed ID: 2852545
    [No Abstract]   [Full Text] [Related]  

  • 26. [Japanese encephalitis vaccine].
    Nakano T
    Nihon Rinsho; 2011 Sep; 69(9):1579-83. PubMed ID: 21922756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural infection with Japanese encephalitis virus among inhabitants of Japan: a nationwide survey of antibodies against nonstructural 1 protein.
    Konishi E; Shoda M; Yamamoto S; Arai S; Tanaka-Taya K; Okabe N
    Vaccine; 2006 Apr; 24(16):3054-6. PubMed ID: 16460843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
    Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
    Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Japanese encephalitis: development of new candidate vaccines.
    Bharati K; Vrati S
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Japanese encephalitis viral infection remains common in Japan.
    Matsunaga T; Shoda M; Konishi E
    Pediatr Infect Dis J; 2008 Aug; 27(8):769-70. PubMed ID: 18600187
    [No Abstract]   [Full Text] [Related]  

  • 31. The first laboratory proven outbreak of Japanese encephalitis in Goa.
    Mohan Rao CV; Prasad SR; Rodrigues JJ; Sharma NG; Shaikh BH; Pavri KM
    Indian J Med Res; 1983 Dec; 78():745-50. PubMed ID: 6325339
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative study of protection by Japanese encephalitis (JE) vaccine against a Japanese strain and an Indian strain of JE virus.
    Das BC; Chakrabarti SK; Sarkar JK; Mukherjee KK
    Indian J Pathol Microbiol; 1976 Oct; 19(4):239-43. PubMed ID: 191395
    [No Abstract]   [Full Text] [Related]  

  • 33. IC51 Japanese encephalitis vaccine.
    Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
    Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Japanese encephalitis epidemic in Western Nepal in 1997.
    Akiba T; Osaka K; Tang S; Nakayama M; Yamamoto A; Kurane I; Okabe N; Umenai T
    Epidemiol Infect; 2001 Feb; 126(1):81-8. PubMed ID: 11293685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004.
    Arai S; Matsunaga Y; Takasaki T; Tanaka-Taya K; Taniguchi K; Okabe N; Kurane I;
    Jpn J Infect Dis; 2008 Sep; 61(5):333-8. PubMed ID: 18806337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on Japanese encephalitis vaccine.
    Can Commun Dis Rep; 1998 Aug; 24():1-8. PubMed ID: 9735509
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand.
    Siraprapasiri T; Sawaddiwudhipong W; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):143-8. PubMed ID: 9322297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A field trial of Japanese encephalitis vaccine produced in Thailand.
    Rojanasuphot S; Charoensuk O; Kitprayura D; Likityingvara C; Limpisthien S; Boonyindee S; Jivariyavej V; Ugchusak K
    Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):653-4. PubMed ID: 2561722
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.